title: Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women.
abstract: Acute exogenous estrogen administration enhances endothelial function in postmenopausal women. To evaluate the effect of endogenous estrogen on endothelium-dependent vasodilation, in 10 fertile normotensive women (age range 45 to 51 years) we studied the changes in forearm blood flow (strain-gauge plethysmography) induced by intrabrachial acetylcholine (0.15, 0.45, 1.5, 4.5, 1.5 micrograms.100 mL-1.min-1), an endothelium-dependent vasodilator, or sodium nitroprusside (1, 2, 4 micrograms.100 mL-1.min-1), an endothelium-independent vasodilator, in basal conditions and within 1 month after ovariectomy. As control subjects, 10 matched healthy women were also evaluated. In basal condition, vasodilation to acetylcholine and sodium nitroprusside was similar in patients and control subjects. Ovariectomy was followed by endogenous estrogen deprivation (from 71.6 +/- 31.3 to < 12 pg/mL) and was associated with a significant (P < .01) reduction in acetylcholine-induced vasodilation compared with baseline (maximum percent increase in forearm blood flow: baseline 568.2 +/- 47.1%; ovariectomy 309.5 +/- 37.4%); the response to sodium nitroprusside was unaffected by ovariectomy (maximum percent increase in forearm blood flow: baseline 526.4 +/- 36.5%; ovariectomy 454.7 +/- 47.2%; P = NS). In 6 of 10 patients, the study was repeated after 3 months of estrogen replacement therapy (17 beta-estradiol, 50 micrograms/d by transdermal patches). Exogenous estrogen restored acetylcholine-induced vasodilation (maximum percent increase in forearm blood flow: 548.9 +/- 43.1%; P < .01 versus ovariectomy), which was no longer different from baseline, whereas the response to sodium nitroprusside was not affected (maximum percent increase in forearm blood flow: 480.2 +/- 39.3%; P = NS). These results suggest a protective role of endogenous estrogen on endothelium-dependent vasodilation in the forearm vascular bed of normotensive women.
authors.affiliation: I Clinica Medica, University of Pisa, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Pinto
authors.forename: A
authors.initials: A
authors.lastname: Virdis
authors.forename: L
authors.initials: L
authors.lastname: Ghiadoni
authors.forename: G
authors.initials: G
authors.lastname: Bernini
authors.forename: M
authors.initials: M
authors.lastname: Lombardo
authors.forename: F
authors.initials: F
authors.lastname: Petraglia
authors.forename: A R
authors.initials: AR
authors.lastname: Genazzani
authors.forename: S
authors.initials: S
authors.lastname: Taddei
authors.forename: A
authors.initials: A
authors.lastname: Salvetti
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000097:blood / Q000502:physiology*; D005260:Female; D006801:Humans; D007889:Leiomyoma / Q000601:surgery; D008875:Middle Aged; D009599:Nitroprusside / Q000494:pharmacology*; D010052:Ovariectomy; D014594:Uterine Neoplasms / Q000601:surgery; D014664:Vasodilation / Q000187:drug effects* / Q000502:physiology; D014665:Vasodilator Agents / Q000494:pharmacology*
chemical_list: D004967:Estrogens; D014665:Vasodilator Agents; D009599:Nitroprusside; D000109:Acetylcholine